ESTRO35 Programme Book

SUNDAY 1 MAY 2016

16:29 > Modelled effects of hypofractionation on radiotherapy demand in England T. Mee (UK), N.F. Kirkby, K.J. Kirkby, R. Jena 16:39 > Evaluation of radiotherapy utilisation in Belgium: patterns and possible causes of suboptimal use Speaker: E. Van Eycken (Belgium), H. De Schutter, K. Stellamans, M. Rosskamp, Y. Lievens 16:57 > Cancer plans in Europe and radiotherapy needs assessment: can we dance a tango? Speaker: T. Albreht (Slovenia) Debate MAXIMISING TUMOUR CONTROL: CRANK UP THE VOLUME OR TURN OFF THE SWITCHES? 16:15 - 17:15 | LONDRA Chair: C. Vens (The Netherlands) Chair: A. Chalmers (UK)

OC-0332

SP-0333

SP-0334

16:15 > For the motion

Speaker: A. Tree (UK)

SP-0335

16:30 > Against the motion

Speaker: J. Sonke (The Netherlands)

SP-0336

16:45 > For the motion rebuttal

Speaker: B. Wouters (Canada)

16:55 > Against the motion rebuttal

Speaker: A. Dekker (The Netherlands)

17:05 > Discussion

Proffered Papers CLINICAL 7: UROLOGY 16:15 - 17:15 | AUDITORIUM Chair: R. Valdagni (Italy) Chair: C. Salembier (Belgium)

16:15 > More acute proctitis symptoms with hypofractionation (3.4 Gy) than 2 Gy fractions W. Heemsbergen (The Netherlands), L. Incrocci, C. Vens, M. Witte, S. Aluwini, F. Pos

OC-0339

SCIENTIFIC PROGRAMME | PROGRAMME AND EXHIBITION GUIDE

111

Made with